Alzheimer's disease
Alzheimer's disease
Evidence-based, peer reviewed, best practice management guidelines for neurologists Diagnosis is only part of the puzzle. Effective treatment is what your patients really want. The European Federation of Neurological Societies has been publishing management guidelines in the European Journal of Neurology for many years. Developed by a consensus approach, using graded evidence, and then fully peer reviewed, these guidelines provide gold-standard, best-practice guidance to the treatment of neurological disorders. They help bridge the gap between what is done and what should be done for patients with neurological disorders.
- University of Florence Italy
- Amsterdam UMC, location VUmc Netherlands
- Amsterdam UMC Netherlands
Alzheimer's disease; Assessment of activities of daily living; Dementia, affecting 5.4% of over-65s-its prevalence further increasing with age; Effects on non-cognitive behavioural and psychological symptoms of dementia (BPSD); European Federation of Neurological Societies (EFNS) recommendations-on diagnosis and management of Alzheimer's disease (AD); Genetics of dementia, complex and genetic testing-associated with ethical concerns; Language praxis and visual-spatial abilities-variably affected according to type and stage of dementia; Management of Alzheimer's disease; Memantine, a non-competitive N-Methyl-D-Aspartate (NMDA) receptor antagonist-subject to several RCTs in AD; Memory functions Memory-especially episodic memory, systematically assessed (Class I)
Alzheimer's disease; Assessment of activities of daily living; Dementia, affecting 5.4% of over-65s-its prevalence further increasing with age; Effects on non-cognitive behavioural and psychological symptoms of dementia (BPSD); European Federation of Neurological Societies (EFNS) recommendations-on diagnosis and management of Alzheimer's disease (AD); Genetics of dementia, complex and genetic testing-associated with ethical concerns; Language praxis and visual-spatial abilities-variably affected according to type and stage of dementia; Management of Alzheimer's disease; Memantine, a non-competitive N-Methyl-D-Aspartate (NMDA) receptor antagonist-subject to several RCTs in AD; Memory functions Memory-especially episodic memory, systematically assessed (Class I)
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!